Freedman R S, Wharton J T, Rutledge F, Sinkovics J G
Am J Obstet Gynecol. 1978 Mar 1;130(5):572-84. doi: 10.1016/0002-9378(78)90081-9.
Dialyzable transfer factor (TFd) is reviewed against its historical background, preparation methods, physiochemical properties, possible mechanisms of action, pharmacology, and clinical studies, including several areas relating to gynecology. The possible role of TFd as an adjunct in the treatment of cancer is discussed. The discussion centers on gynecologic cancer in several patients who have received TFd. The difficulties and future possibilities for this modality of treatment are considered.
针对可透析转移因子（TFd），本文从其历史背景、制备方法、理化性质、可能的作用机制、药理学以及临床研究（包括与妇科相关的几个领域）等方面进行了综述。讨论了TFd作为癌症治疗辅助手段的可能作用。讨论集中在几位接受过TFd治疗的患者的妇科癌症上。同时考虑了这种治疗方式的困难和未来可能性。
